| # | Holder | Shares | % of Shares Out | Change | Filing Date |
|---|---|---|---|---|---|
| 1 |
Karkus (Ted William)
|
321.533k | 2.29% | — | Apr 29 2025 |
| 2 |
Gleckel (Louis)
|
10.384k | 0.07% | — | Apr 29 2025 |
| 3 |
MRB Fund Partners AG
|
5.000k | 0.04% | — | Feb 28 2026 |
| 4 |
Swisspartners Investment Network AG
|
5.000k | 0.04% | — | Dec 31 2024 |
| 5 |
BofA Global Research (US)
|
114.000 | 0.00% | +2.000 | Dec 31 2025 |
|
1
Karkus (Ted William)
|
2.29%
321.533k
|
|
2
Gleckel (Louis)
|
0.07%
10.384k
|
|
3
MRB Fund Partners AG
|
0.04%
5.000k
|
|
4
Swisspartners Investment Network AG
|
0.04%
5.000k
|
|
5
BofA Global Research (US)
|
0.00%
114.000
|
| The largest shareholders show who really holds influence: big institutional owners shape a stock's liquidity, and building or cutting positions can move the price. | |
| The 5 largest shareholders together hold 2.44% of ProPhase Labs, Inc., with Karkus (Ted William) the biggest at 2.29%, followed by Gleckel (Louis) (0.07%) and MRB Fund Partners AG (0.04%). |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


